Now Playing
Opinion|Videos|July 3, 2024
Patient vs Provider Perceptions: Expert Opinions on Addressing the Emotional Impact of Vitiligo
Author(s)Latanya Benjamin, MD, FAAD, FAAP
Highlighting the emotional impact of vitiligo on patients, Latanya Benjamin, MD, FAAD, FAAP, presents the case of a 35-year-old female patient with growing depigmentation in highly visible areas.
Advertisement
Episodes in this series
Advertisement
Related to this article
The FDA clearance allows Edesa to expand an ongoing placebo-controlled study of the CXCL10 antibody EB06 to US sites, with topline data expected in the fourth quarter of 2027.
Dermatology clinicians at a Case-Based Roundtable in Austin, Texas, discussed real-world strategies for sequencing topical therapy, phototherapy, and ruxolitinib cream across pediatric and adult vitiligo cases.
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
2
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
3
GLP-1 Candidacy and Prescribing Considerations in Psoriasis
4
Bitopertin Meets All End Points in Phase 3 APOLLO Trial for EPP
5